Cara Therapeutics, Inc. (CARA) Financials

CARA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 125.8 million 68.8 million
2023-09-30 115.3 million 29.7 million
2023-06-30 134.4 million 25.5 million
2023-03-31 153.3 million 16.7 million

CARA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -19.4 million 3.6 million
2023-09-30 -20.0 million 3.3 million
2023-06-30 -20.4 million 3.4 million
2023-03-31 -34.6 million 3.4 million

CARA Net Income

No data available :(

CARA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 101.2 million - 6.1 million
2023-09-30 78.5 million - 7.3 million
2023-06-30 94.7 million - 982000
2023-03-31 114.3 million - 1.5 million

CARA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 54.5 million
2023-09-30 54.2 million
2023-06-30 54.0 million
2023-03-31 53.9 million

CARA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 2.1 million 28.4 million 6.5 million -
2023-09-30 323000 25.5 million 6.8 million -
2023-06-30 323000 30.3 million 7.5 million -
2023-03-31 323000 24.3 million 6.9 million -

CARA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 3.0 million 690000
2023-09-30 4.9 million 1.6 million
2023-06-30 6.9 million 1.4 million
2023-03-31 6.2 million 2.6 million

CARA

Price: $0.78

52 week price:
0.50
4.67

Earnings Per Share: -2.19 USD

P/E Ratio: -0.27

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 393100

Ebitda: -12.8 million

Market Capitalization: 46.5 million

Links: